Astellas Announces Cancellation of Treasury Shares (pdf 266KB)
(WorldNews Japan)

Press Release Astellas Announces Cancellation of Treasury Shares Tokyo, Japan, April 27, 2017 - Astellas Pharma Inc. (TSE: 4503; President and CEO: Yoshihiko Hatanaka, hereinafter called "the Company") announced that at the meeting of the Board of Directors held today, a resolution was adopted that the Company will cancel its treasury shares, pursuant to Article 178 of the Companies Act. Particulars Class of shares to be cancelled Common stock of the Company Number of shares to be cancelled 85 million shares (Representing 3.95% of issued shares prior to cancellation) Cancellation...